日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial

作者更正:一线改良FOLFOX方案联合/不联合纳武利尤单抗和伊匹木单抗或FLOT方案联合纳武利尤单抗治疗晚期胃食管腺癌:一项II期多队列IKF-AIO-MOONLIGHT试验

Lorenzen, Sylvie; Goetze, Thorsten Oliver; Thuss-Patience, Peter C; Riera-Knorrenschild, Jorge; Goekkurt, Eray; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Hofheinz, Ralf Dieter; Luley, Kim Barbara; Pink, Daniel; Lindig, Udo; Folprecht, Gunnar; Schuch, Gunter; Bitzer, Michael; Heinemann, Volker; Angermeier, Stefan; Bolling, Claus; Loose, Maria; Junge, Sabine; Pauligk, Claudia; Al-Batran, Salah-Eddin

First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial

一线改良FOLFOX方案联合/不联合纳武利尤单抗和伊匹木单抗或FLOT方案联合纳武利尤单抗治疗晚期胃食管腺癌:一项II期多队列试验

Lorenzen, Sylvie; Goetze, Thorsten Oliver; Thuss-Patience, Peter C; Riera-Knorrenschild, Jorge; Goekkurt, Eray; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Hofheinz, Ralf Dieter; Luley, Kim Barbara; Pink, Daniel; Lindig, Udo; Folprecht, Gunnar; Schuch, Gunter; Bitzer, Michael; Heinemann, Volker; Angermeier, Stefan; Bolling, Claus; Loose, Maria; Junge, Sabine; Pauligk, Claudia; Al-Batran, Salah-Eddin

Survival after pathological complete response following neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal squamous cell carcinoma

食管鳞状细胞癌新辅助化疗与放化疗后病理完全缓解后的生存率比较

Okui, Jun; Matsuda, Satoru; Nagashima, Kengo; Sato, Yasunori; Kawakubo, Hirofumi; Ruhstaller, Thomas; Thuss-Patience, Peter; Nilsson, Magnus; Klevebro, Fredrik; Tan, Lijie; Zhang, Shaoyuan; Aparicio, Thomas; Piessen, Guillaume; van der Zijden, Charlène; Mostert, Bianca; Wijnhoven, Bas P L; Tsushima, Takahiro; Takeuchi, Hiroya; Kato, Ken; Kitagawa, Yuko

Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials

根治性食管切除术后条件性无复发生存率:11项试验的个体患者数据分析

Okui, Jun; Matsuda, Satoru; Nagashima, Kengo; Sato, Yasunori; Kawakubo, Hirofumi; Ruhstaller, Thomas; Thuss-Patience, Peter; Nilsson, Magnus; Klevebro, Fredrik; Tan, Lijie; Zhang, Shaoyuan; Aparicio, Thomas; Piessen, Guillaume; van der Zijden, Charlène; Mostert, Bianca; Wijnhoven, Bas P L; Tsushima, Takahiro; Takeuchi, Hiroya; Kato, Ken; Kitagawa, Yuko

Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials

评估病理完全缓解作为可切除食管癌总生存期的替代终点:对 III 期试验中个体患者数据的综合分析

Okui, Jun; Nagashima, Kengo; Matsuda, Satoru; Sato, Yasunori; Kawakubo, Hirofumi; Ruhstaller, Thomas; Thuss-Patience, Peter; Nilsson, Magnus; Klevebro, Fredrik; Tan, Lijie; Zhang, Shaoyuan; Aparicio, Thomas; Piessen, Guillaume; van der Zijden, Charlène; Mostert, Bianca; Wijnhoven, Bas P L; Tsushima, Takahiro; Takeuchi, Hiroya; Kato, Ken; Kitagawa, Yuko

Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy

炎症应激决定接受靶向治疗和免疫治疗的HER2阳性食管胃腺癌患者是否需要化疗

Tintelnot, Joseph; Paschold, Lisa; Goekkurt, Eray; Schultheiss, Christoph; Matschl, Urte; Santos Cruz, Mariana; Bauer, Marcus; Wickenhauser, Claudia; Thuss-Patience, Peter; Lorenzen, Sylvie; Ettrich, Thomas J; Riera-Knorrenschild, Jorge; Jacobasch, Lutz; Kretzschmar, Albrecht; Kubicka, Stefan; Al-Batran, Salah-Eddin; Reinacher-Schick, Anke; Pink, Daniel; Bokemeyer, Carsten; Sinn, Marianne; Lindig, Udo; Hinke, Axel; Hegewisch-Becker, Susanna; Stein, Alexander; Binder, Mascha

German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus-version 4.0

德国食管鳞状细胞癌和腺癌诊断和治疗指南 - 4.0 版

Ebert, M P; Fischbach, W; Hollerbach, S; Höppner, J; Lorenz, D; Stahl, M; Stuschke, M; Pech, O; Vanhoefer, U; Bruns, C; Ell, C; Follmann, M; Goerling, U; Grenacher, L; Haardt, J; Hölscher, A H; Hummel, R; Knoefel, W T; Körber, J; Langer, R; Lenz, P; Lordick, F; Lorenzen, S; Meining, A G; Menzel, J; Meyer, H-J; Nicolay, N H; Nothacker, M; Nöthlings, U; Schmidberger, H; Schmidt, M; Seufferlein, T; Thuss-Patience, P; Trojan, J; Weimann, A; Klug, L; Lynen, P; Zhan, T; Xiao, Q; Porschen, R

Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial

热灌注腹腔化疗对同步性腹膜转移胃癌细胞减灭术的影响:III期GASTRIPEC-I试验

Rau, Beate; Lang, Hauke; Koenigsrainer, Alfred; Gockel, Ines; Rau, Horst-Guenter; Seeliger, Hendrik; Lerchenmueller, Christian; Reim, Daniel; Wahba, Roger; Angele, Martin; Heeg, Steffen; Keck, Tobias; Weimann, Arved; Topp, Stefan; Piso, Pompiliu; Brandl, Andreas; Schuele, Silke; Jo, Peter; Pratschke, Johann; Wegel, Sandra; Rehders, Alexander; Moosmann, Nicolas; Gaedcke, Jochen; Heinemann, Volker; Trips, Evelyn; Loeffler, Markus; Schlag, Peter Michael; Thuss-Patience, Peter

Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial

雷莫芦单抗、阿维鲁单抗和紫杉醇作为食管胃腺癌二线治疗:RAP (AIO-STO-0218) II期非随机对照试验

Thuss-Patience, Peter; Högner, Anica; Goekkurt, Eray; Stahl, Michael; Kretzschmar, Albrecht; Götze, Thorsten; Stocker, Gertraud; Reichardt, Peter; Kullmann, Frank; Pink, Daniel; Bartels, Prisca; Jarosch, Armin; Hinke, Axel; Schultheiß, Christoph; Paschold, Lisa; Stein, Alexander; Binder, Mascha

Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study

Tislelizumab 与化疗作为欧洲和北美晚期或转移性食管鳞状细胞癌患者二线治疗的比较:一项随机 III 期 RATIONALE-302 研究的亚组分析

Ajani, J; El Hajbi, F; Cunningham, D; Alsina, M; Thuss-Patience, P; Scagliotti, G V; Van den Eynde, M; Kim, S-B; Kato, K; Shen, L; Li, L; Ding, N; Shi, J; Barnes, G; Van Cutsem, E